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26
Novel viruses belonging to the genera Hepacivirus and Pegivirus have recently been 27 discovered in horses and other animal species. Viral genomes of non-primate hepaciviruses 28 (NPHV), equine pegivirus 1 (EPgV 1) and Theiler's disease associated virus (TDAV) were 29 detected in a horse serum routinely used for cell culture propagation in our laboratory.
30
Therefore, a study was carried out to further investigate the presence of these human Hepatitis 
58
About 0.9%-2.5 % of equine sera from different European countries were found to contain 59 NPHV RNA (Lyons et al., 2014; Pfaender et al., 2014b ). An overall NPHV RNA prevalence 60 of approx. 2.5% was observed in Northern Germany, but a significantly higher prevalence of 61 10.4% was found in Thoroughbred horses (Pfaender et al., 2014b) . Reasons for this 62 observation remain elusive, but it can be speculated that genetic determinants or alternatively 63 an increased exposure to the pathogen might be responsible. Interestingly, a comparatively 64 high NPHV genome prevalence of 22.6% (7/31 sera) was recognized in Japanese-born 65 domestic horses (Tanaka et al., 2014) . EPgV 1 genomes were detected with 9.5% prevalence 66 (7/74 horses) in the US and approximately 3.8% prevalence (12/328 horses) in Scotland, 
70
The presence of hepaci-and pegiviruses in equine sera could have significant consequences.
71
Horse sera are commonly used for the production of anti-sera. Such anti-sera are licensed for various treatments of different animal species including tetanus prophylaxis as well as for of NPHV and pegivirus genomes in equine sera in order to shed light on the biosecurity 88 aspect of commercially available horse sera and in products containing horse sera.
89
Independently of the geographic origin, high amounts of NPHV and pegivirus RNA could be 90 detected in serum batches used for commercial purposes. Furthermore, the presence of TDAV Horses, University of Veterinary Medicine Hannover, Germany, and were already 107 investigated for presence of NPHV genomes in a previous study (Pfaender et al., 2014b) . The (Table 1) .
119
For detection and simultaneous differentiation between EPgV 1 and TDAV-, a primer pair by primer walking using TDAV-B2 and TDAV-B10 specific primers as listed in Table 1 .
168
Results
169
Development of a highly sensitive pegivirus specific triplex real-time RT-PCR
170
The designed primers proved to bind specifically to synthetic run-off transcripts of TDAV as The developed triplex real-time PCR revealed high viral genome titers in a commercial horse 185 serum routinely used for cell culture propagation in our laboratory ( RNA, including a fetal horse serum, which was the only one to be negative for NPHV 189 genome (Table 2) . NPHV genome titers were very low in commercial sera originating from of at least six different NPHV genome types in this commercial serum (Fig. 1A) . (Fig. 1B) . All of the nine EPgV 1 sequences were distinct to the EPgV 1 reference 218 sequence "C0035" (6-10% genetic distance) and the PCR control "WST" [KT795380] .
219
EPgV 1 sequences displayed up to 12% genetic distance among each other, but only for two were detected in 16 sera (13.5%) from both premises (suppl. Fig.) . No apparent differences in
265
EPgV 1 RNA prevalence were observed between the premise with Warmblood horses
266
(12.2 %) and the premise with Thoroughbreds (14.1%). In all cases, multiplex PCR identified 267 the pegiviruses as EPgV 1 and no TDAV was detected. Interestingly, four out of ten (40%)
268
NPHV positive samples revealed a simultaneous infection with EPgV 1 (suppl. Fig.) . The 269 mean value of genome loads was conspicuously higher for NPHV (1.5 x 10 7 genome 270 equivalents/ml) than for EPgV 1 (1.7 x 10 5 genomes/ml) (Fig. 2) . for research groups studying pestiviruses, HCV or other related viruses (Yanagi et al., 1996) .
351
Besides the biosecurity aspect, the presence of viral RNA, infectious virus or cross-reacting with viral RNAs must also be considered when applying highly sensitive, unbiased methods
355
like deep-sequencing from cell culture derived virus isolates.
356
In conclusion, the recent discovery of equine NPHV, EPgV 1 and TDAV requires a thorough Inga Grotha who contributed in the initial phase of the project. 
